News
Dementia and digital health – progress report

The Alzheimer’s Society estimates that there are 850,000 people with dementia in the UK, a figure that is projected to rise to 1.6 million by 2040. At the moment, there is no cure for the condition and no real way of treating it, although research is continuing all the time. However, a range of digital health innovations could alleviate the worst of the symptoms, and may even go some way to preventing it.
Dementia is a term covering a range of different conditions, all of which manifest themselves in a deterioration of cognitive function, such as memory loss, difficulty concentrating and mood changes.
Alzheimer’s disease is the most common type of dementia, affecting between 50 and 75 per cent of those diagnosed.
Other types of dementia include: vascular dementia, which affects up to 20 per cent of those diagnosed; frontotemporal dementia, which affects two per cent; and dementia with Lewy bodies, which accounts for between 10 and 15 per cent.
However, while there is no treatment for any of the types of dementia, tech is playing its part in improving the outlook.
Brain training
When it comes to cognitive function, many scientists believe it’s a case of use it or lose it.
As such, they encourage taking part in regular mental activities designed to help maintain or even increase a person’s cognitive abilities, such as attention, reasoning and problem solving.
Over recent years, brain training activities have become more advanced, harnessing the power of tech to offer apps and games that can improve cognitive function.
Apps such as BrainHQ offer a full range of activities focusing on different elements of the brain, such as memory, attention and brain speed.
And in 2017, a team from the University of Cambridge created an app called Game Show, to help users improve their attention and concentration. Results showed that patients who played the game improved their memory score by around 40 per cent.
While more research is needed into whether brain training can definitely prevent dementia, it can definitely help to sharpen cognitive skills – which can only be a good thing.
Virtual reality
In 2019, a study demonstrated how virtual reality, or VR could help even those with advanced dementia.
The research was led by Dr. Chee Siang (Jim) Ang, a senior lecturer from University of Kent, and used VR devices on eight patients in a psychiatric facility.
Each participant used a VR headset to visit five virtual locations: the countryside, a sandy beach, a rocky beach, a cathedral, and a forest. The patients got to choose their own environment.
The team found that VR helped the participants recall old memories, by offering new stimuli that they could otherwise not attain due to illness or inaccessibility.
It also gave caregivers a way of learning more about the patients’ lives, which improved their social interactions, allowing for more holistic care.
Artificial intelligence
Artificial intelligence, or AI, is often used to spot patterns, meaning it is a useful tool in diagnosing conditions and illnesses.
In 2021, scientists from Cambridge University and The Alan Turing Institute developed machine learning tools which can detect dementia in patients up to 15 to 20 years earlier than current processes.
Cellular changes to the brain usually occur a number of years before symptoms appear and it can take a long time and multiple hospital visits to diagnose dementia.
However, the new technology spots structural changes to the brain from a single brain scan by identifying patterns using previous research and memory tests. The findings provide a prognostic score, which is the likelihood of the patient having the disease.
Digital assistants
Voice-activated tech such as Siri and Alexa can bring huge benefits to the health and wellbeing of people with dementia and their carers.
An NHS Digital project in 2020 loaned technology such as iPads and Alexa devices to support groups and Memory Cafes, as well as given to carers to use at home.
The technology had an incredibly positive impact, with one carer saying it had “changed her and her dad’s life” after she used it for medication, exercise and appointment reminders.
Other users reported that the devices had made them feel less isolated, as well as offering practical benefits, such as enabling them to manage medication or get health information.
In addition to loaning out technology, the Leeds Dementia Pathfinder – which was run by 100% Digital Leeds alongside community partners – provided training and resources for users to ensure they made the most of the equipment.
A simple smartphone
Around 80 per cent of the world’s population owns a smartphone, and while the younger generation may use theirs for gaming and streaming, they can provide vital support for dementia patients too.
Results from a study published in the Journal of the American Geriatrics Society found that older adults with mild dementia can learn to use smartphone memory aids to help them remember to complete everyday tasks.
In the study, 52 older adults with mild cognitive impairment or mild dementia were trained how to use a digital voice recorder or reminder app.
After four weeks, participants reported improvements in performing regular daily tasks, with greater usage of the apps associated with better results.
News
Gut-friendly foods may damage heart, charity warns
News
Diabetes patients face increased risk of undiagnosed heart failure

People with diabetes may have undiagnosed heart failure that could be detected by a simple screening blood test, research suggests.
The TARTAN-HF trial found that one in four patients with diabetes who had at least one other risk factor for heart failure had undiagnosed heart failure detected through screening with a blood test and ultrasound scanning of the heart.
Experts said the findings show the extent of unrecognised heart failure in people with diabetes, and how the condition can be detected using a widely available blood test called NT-proBNP, which measures how much strain the heart is under.
They suggest a heart failure screening programme for diabetics could improve diagnosis rates, lead to earlier treatment and potentially reduce the risk of hospitalisation and death.
The study, involving 700 patients, was led by the University of Glasgow in collaboration with AstraZeneca, Roche Diagnostics, Us2.ai, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
Dr Kieran Docherty, clinical senior lecturer at the University of Glasgow’s School of Cardiovascular and Metabolic Health, said: “Our results from the landmark TARTAN-HF trial identified heart failure in a large proportion of people living with diabetes, emphasising the need for a heart failure screening strategy in this group of patients.
“We know that many of the symptoms and signs of heart failure are non-specific, and may go unrecognised as potentially being due to heart failure for a long time.
“The strategy used in our trial is simple and easy to implement in clinical practice, and will aid in the early identification of heart failure in people with diabetes, and facilitate the initiation of medications that we know improve outcomes in patients with heart failure.”
The study, which began more than three years ago, involved more than 700 people with diabetes from the two health board areas who had at least one other risk factor for heart failure.
They were randomly assigned either to receive heart failure screening or to continue with their usual care.
Researchers found screening uncovered a large number of previously unrecognised cases of heart failure. Around one in four, or 24.9 per cent, of those screened were found to have the condition within six months, compared with 1 per cent in the group continuing their usual care.
The study, involving patients with type 1 and type 2 diabetes, found almost all of the participants found to have heart failure had preserved ejection fraction, which can be difficult to detect without dedicated testing.
The findings of the TARTAN-HF trial were presented at the American College of Cardiology conference taking place from 28 to 30 March in New Orleans in the US.
Dr Edward Piper, medical director at AstraZeneca UK, said: “Delayed diagnosis and treatment of heart failure in people with type 2 diabetes contributes to poor long-term outcomes. TARTAN-HF demonstrates that targeted, risk-based screening can identify previously undiagnosed heart failure in approximately one in four high-risk patients with diabetes, enabling earlier intervention with guideline-directed therapy.”
Dr Christian Simon, head of global medical affairs at Roche Diagnostics, said: “We are proud to have supported the landmark TARTAN-HF trial. These findings demonstrate the transformative power of early, accessible diagnostics like the NT-proBNP blood test.
“By identifying unrecognised heart failure in people with diabetes, we enable clinicians to initiate appropriate treatments sooner, ultimately improving patient outcomes and lives.”
News
UK government announces £6.3m fund to boost men’s health

The UK has launched a £6.3m men’s health fund to back local projects aimed at helping men and boys live longer, healthier lives.
The Men’s Health Community Fund is a partnership between the Department of Health and Social Care, Movember and People’s Health Trust.
The government is contributing £3m, while the two charities are more than doubling that to take the total to £6.3m.
Grants will support community projects reaching underserved men and boys aged 16 and over, particularly in the most disadvantaged areas and at key points in their lives such as becoming a father, losing a job or retiring.
Projects could include support for new fathers, activities for men facing loneliness and social isolation, services to help young men engage with the health system, and support for men in work, out of work and moving into retirement.
The programme will bring together voluntary, community and social enterprise organisations to test new ways of reaching men who are least likely to use traditional health services.
An evaluation funded through the National Institute for Health and Care Research will assess what works and help inform future policy and delivery.
Health and social care secretary Wes Streeting said: “Too many men across the country are living shorter, less healthy lives, particularly those in our most disadvantaged communities.
“This new partnership will help men get the support they need in the places they feel most comfortable, their communities, among people they trust.
“By working with expert charities and local organisations, we can reach the men who are too often missed by traditional services and help them take better care of their mental and physical health.”
“It is a key step in delivering our first ever Men’s Health Strategy and driving forward our ambition to halve the gap in healthy life expectancy between the richest and poorest areas.”
The Men’s Health Strategy sets out plans to tackle the physical and mental health challenges men and boys face.
Men can be less likely to seek help and more likely to suffer in silence, while higher rates of smoking, drinking, gambling and drug use are damaging men’s health and affecting families, workplaces and communities.
The government is also investing £3.6m over the next three years in suicide prevention projects for middle-aged men in local communities across areas of England where men are most at risk, many of which are also among the most deprived. Suicide is one of the biggest killers of men under 50, and three-quarters of all suicides are men.
The projects will aim to break down barriers middle-aged men face in seeking support, including stigma around asking for help and a lack of awareness of what is available and how to access it.
They will be co-designed with experts and men with lived experience of mental health crises and suicidal thoughts.
News4 weeks agoCentenarian study probes healthy ageing
News4 weeks agoActive sitting linked to lower dementia risk
News4 weeks agoEndogenex raises US$50m for diabetes procedure
Wellness4 weeks agoWorking nights undermines type 2 diabetes management – study
News4 weeks agoUK government announces £6.3m fund to boost men’s health
News4 weeks agoBrain health collaboratory launches in Gulf South
Technology4 weeks agoSocial isolation is a horrible consequence of dementia – AI could be an answer
News3 weeks agoDiabetes patients face increased risk of undiagnosed heart failure











